Atlas Therapeutics Corp (ATTH) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 14 transactions totaling $1.7K, demonstrating a bullish sentiment with $1.7K in net insider flow. The most recent transaction on May 7, 2012 involved a transaction of 250,000 shares valued at $0.
No significant insider buying has been recorded for ATTH in the recent period.
No significant insider selling has been recorded for ATTH in the recent period.
Based on recent SEC filings, insider sentiment for ATTH is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.7K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Atlas Therapeutics Corp (ATTH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading ATTH stock, having executed 14 transactions in the past 90 days. The most active insider is Janine Divenuto (Executive), who has made 8 transactions totaling $1.7K.
Get notified when executives and directors at ATTH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 7, 2012 | Levy Peter | Executive | Award | 250,000 | $N/A | $0 | |
| Feb 10, 2012 | Levy Peter | Executive | Award | 500,000 | $N/A | $0 | |
| Nov 29, 2011 | J. Hariri Robert | Executive | Award | 150,000 | $N/A | $0 | |
| Oct 14, 2011 | Divenuto Janine | Executive | Purchase | 1,000 | $0.24 | $240 | |
| Oct 11, 2011 | Divenuto Janine | Executive | Purchase | 1,000 | $0.20 | $200 | |
| Oct 10, 2011 | Divenuto Janine | Executive | Purchase | 1,000 | $0.20 | $200 | |
| Oct 6, 2011 | Divenuto Janine | Executive | Purchase | 2,000 | $0.24 | $480 | |
| Oct 3, 2011 | Divenuto Janine | Executive | Purchase | 700 | $0.30 | $210 | |
| Oct 3, 2011 | Divenuto Janine | Executive | Purchase | 400 | $0.32 | $128 | |
| Oct 3, 2011 | Divenuto Janine | Executive | Purchase | 500 | $0.29 | $145 | |
| Sep 30, 2011 | Divenuto Janine | Executive | Purchase | 400 | $0.32 | $128 | |
| Aug 15, 2011 | Diamandis Peter | Executive | Award | 100,000 | $N/A | $0 | |
| Jul 26, 2011 | J. Hariri Robert | Executive | Award | 100,000 | $N/A | $0 | |
| Jul 14, 2011 | J. Aronne Louis | Executive | Award | 600,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 8 | $1.7K | 100.0% |
Award(A) | 6 | $0 | 0.0% |
Insiders at Atlas Therapeutics Corp are accumulating shares at an accelerated pace. With 5 insiders making 14 transactions totaling $1.7K in purchases versus $0 in sales, the net buying activity of $1.7K signals strong executive confidence. Janine Divenuto (Executive) leads the buying activity with $1.7K in transactions across all time.